The Gene Panel Market is expanding as healthcare providers increasingly use targeted genetic testing for cancer assessment, inherited disorders, and personalized medicine. Market Research Future estimates the market at USD 3.56 billion in 2025 and projects it to reach USD 14.03 billion by 2035, registering a 14.58% CAGR.
Advances in next-generation sequencing are making it easier to examine multiple genes in a single test. Amplicon-based and hybridization-based techniques are being improved to deliver broader coverage, faster workflows, and more efficient genomic analysis.
Cancer risk assessment remains a major application for gene panels, while pharmacogenetics and hereditary disease testing are creating additional opportunities. Hospitals, clinics, and diagnostic laboratories are increasingly incorporating panel testing into molecular diagnostic workflows.
North America accounted for 38.95% of market revenue in 2025, while Asia-Pacific is projected to grow at a 15.25% CAGR through 2035. Expanding genomics programs, improving laboratory infrastructure, and rising demand for precision medicine are supporting regional growth.
Future opportunities are emerging around AI-assisted variant interpretation, pharmacogenomic testing, newborn screening, and population genomics. Greater integration of sequencing platforms with bioinformatics and clinical reporting could further expand the role of gene panels in modern healthcare.
Dive into related studies for a broader industry perspective:
Germany Medical Vacuum Systems Market Trends
UK Cardiac Biomarkers Market Growth
Japan Disposable Nitrile Gloves Market Demand
